Skip to content

Interventional Endoscopy Database for Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Endoscopic Retrograde Cholangiopancreatography, Endoscopic Ultrasound and Interventional Endoscopy in Pancreatico-biliary, Gastrointestinal and Esophageal Disorders

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01438385
Enrollment
12000
Registered
2011-09-22
Start date
2011-07-31
Completion date
2017-12-30
Last updated
2017-02-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute and Chronic Pancreatitis, Ampullary Cancer, Barrett's Esophagus, Bile Duct Cancer, Bile Duct Disorders, Bile Leak, Biliary and Pancreatic Stones, Biliary Strictures, Cholangiocarcinoma, Cholangitis, Choledocholithiasis, Colorectal Cancer, Duodenal Cancer, Esophageal Cancer, Gallstones, Gastric Malignancies, Obstructive Jaundice, Pancreatic Cancer, Pancreatic Disorders (Noncancerous), Pancreatic Divisum, Pancreatic Pseudocysts, Pediatric Gastroenterology, Recurrent Pancreatitis

Keywords

Pancreatico-biliary, Biliary, Bile Duct, Gastrointestinal disorder, Esophageal disorder

Brief summary

Our institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ), Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year. Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal disorders. The investigators would like to assess prospectively the efficacy and safety of these routine procedures to permit identification of technical details about the procedures or other factors which might be associated with outcome or results. Assessment of these details would help us with problem identification and recommendations to improve health outcomes and quality of life in these patients.

Detailed description

Our institution performs therapeutic ERCP (Endoscopic retrograde cholangiopancreatography ), Endoscopic Ultrasound (EUS) and Interventional Endoscopy in around 1000 patients a year. Procedures such as biliary and/or pancreatic sphincterotomy, stents placement (metallic or plastic) and removal for revision, cysts and pseudocysts drainage are conducted in patients suffering from pancreatico-biliary disorders, gastrointestinal disorders and esophageal disorders. The investigators would like to assess prospectively the efficacy and safety of these routine procedures to permit identification of technical details about the procedures or other factors which might be associated with outcome or results. Assessment of these details would help us with problem identification and recommendations to improve health outcomes and quality of life in these patients.

Interventions

Advanced imaging endoscopic or therapeutic endoscopy

Sponsors

Weill Medical College of Cornell University
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Any subject that underwent Interventional Endoscopy for Pancreatico-biliary, Gastrointestinal or Esophageal disorders. * Above the age of 18 years

Exclusion criteria

* Any group that did not undergo Interventional Endoscopy for Pancreatico-biliary, Gastrointestinal or Esophageal disorders. * Below the age of 18 years

Design outcomes

Primary

MeasureTime frameDescription
Establishing a database that contains all Interventional Endoscopies5 yearsCollection of procedure specific details of all Interventional Endoscopies

Countries

United States

Contacts

Primary ContactMichel Kahaleh, MD
mik9071@med.cornell.edu646-962-4000
Backup ContactMonica R Gaidhane, MD, MPH
mog2012@med.cornell.edu646-962-4796

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 13, 2026